321 related articles for article (PubMed ID: 34064969)
1. Initiation of Pancreatic Cancer: The Interplay of Hyperglycemia and Macrophages Promotes the Acquisition of Malignancy-Associated Properties in Pancreatic Ductal Epithelial Cells.
Otto L; Rahn S; Daunke T; Walter F; Winter E; Möller JL; Rose-John S; Wesch D; Schäfer H; Sebens S
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064969
[TBL] [Abstract][Full Text] [Related]
2. Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells.
Rahn S; Zimmermann V; Viol F; Knaack H; Stemmer K; Peters L; Lenk L; Ungefroren H; Saur D; Schäfer H; Helm O; Sebens S
Cancer Lett; 2018 Feb; 415():129-150. PubMed ID: 29222037
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
[TBL] [Abstract][Full Text] [Related]
4. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
5. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
[TBL] [Abstract][Full Text] [Related]
6. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8.
Chen SJ; Lian GD; Li JJ; Zhang QB; Zeng LJ; Yang KG; Huang CM; Li YQ; Chen YT; Huang KH
Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406
[TBL] [Abstract][Full Text] [Related]
7. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161
[TBL] [Abstract][Full Text] [Related]
8. Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality.
van Pelt J; Meeusen B; Derua R; Guffens L; Van Cutsem E; Janssens V; Verslype C
J Transl Med; 2023 May; 21(1):317. PubMed ID: 37170215
[TBL] [Abstract][Full Text] [Related]
9. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
10. Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition.
Mizuuchi Y; Aishima S; Ohuchida K; Shindo K; Fujino M; Hattori M; Miyazaki T; Mizumoto K; Tanaka M; Oda Y
Lab Invest; 2015 Feb; 95(2):193-206. PubMed ID: 25418581
[TBL] [Abstract][Full Text] [Related]
11. Liver metastasis of pancreatic cancer: the hepatic microenvironment impacts differentiation and self-renewal capacity of pancreatic ductal epithelial cells.
Knaack H; Lenk L; Philipp LM; Miarka L; Rahn S; Viol F; Hauser C; Egberts JH; Gundlach JP; Will O; Tiwari S; Mikulits W; Schumacher U; Hengstler JG; Sebens S
Oncotarget; 2018 Aug; 9(60):31771-31786. PubMed ID: 30167093
[TBL] [Abstract][Full Text] [Related]
12. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
13. CD4
Goebel L; Grage-Griebenow E; Gorys A; Helm O; Genrich G; Lenk L; Wesch D; Ungefroren H; Freitag-Wolf S; Sipos B; Röcken C; Schäfer H; Sebens S
Oncoimmunology; 2015 Apr; 4(4):e1000083. PubMed ID: 26137395
[TBL] [Abstract][Full Text] [Related]
14. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
Yuan Q; Zhang Y; Feng L; Jiang Y
J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
[TBL] [Abstract][Full Text] [Related]
15. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.
Liu CY; Xu JY; Shi XY; Huang W; Ruan TY; Xie P; Ding JL
Lab Invest; 2013 Jul; 93(7):844-54. PubMed ID: 23752129
[TBL] [Abstract][Full Text] [Related]
16. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
17. Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent.
Schäfer H; Geismann C; Heneweer C; Egberts JH; Korniienko O; Kiefel H; Moldenhauer G; Bachem MG; Kalthoff H; Altevogt P; Sebens S
Carcinogenesis; 2012 Jan; 33(1):84-93. PubMed ID: 22095073
[TBL] [Abstract][Full Text] [Related]
18. CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Li K; Xu B; Xu G; Liu R
Tumour Biol; 2016 Jan; 37(1):419-24. PubMed ID: 26219899
[TBL] [Abstract][Full Text] [Related]
19. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.
Incio J; Suboj P; Chin SM; Vardam-Kaur T; Liu H; Hato T; Babykutty S; Chen I; Deshpande V; Jain RK; Fukumura D
PLoS One; 2015; 10(12):e0141392. PubMed ID: 26641266
[TBL] [Abstract][Full Text] [Related]
20. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
[No Abstract] [Full Text] [Related]
[Next] [New Search]
